Company ABL Bio Inc.

Equities

A298380

KR7298380007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

EPS Revisions

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
26,000 ^KRW	-1.52%		+12.80%	+5.69%

Mar. 25	Biocytogen Pharmaceuticals Co., Ltd. Enters Collaboration with ABL Bio Inc. to Develop New Bispecific Antibody-Drug Conjugates	CI
2023	ABL Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

ABL Bio Inc. is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

KRW in Million	2022	Weight	2023	Weight	Delta
Bio-Protein Recombinant Medicines 100.0 %	67,301	100.0 %	65,547	100.0 %	-2.61%

KRW in Million	2022	Weight	2023	Weight	Delta
United States 97.0 %	62,315	92.6 %	63,551	97.0 %	+1.98%
South Korea 3.0 %	2,384	3.5 %	1,996	3.0 %	-16.30%

Managers	Title	Age	Since
Sang-Hoon Lee FOU	Founder	61	16-02-15
Jae-Cheon Lee DFI	Director of Finance/CFO	54	-
Won-Gyu Yoo PRN	Corporate Officer/Principal	56	-

Members of the board	Title	Age	Since
Sang-Hoon Lee FOU	Founder	61	16-02-15
Jae-Cheon Lee DFI	Director of Finance/CFO	54	-
Dong-Yoon Kim BRD	Director/Board Member	54	-
Nam-Woo Lee BRD	Director/Board Member	60	19-03-20
Jung-Hye Choi BRD	Director/Board Member	45	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	47,892,539	33,005,124 ( 68.91 %)	0	68.91 %

Name	Equities	%	Valuation
Sang-Hoon Lee 26.52 %	12,700,000	26.52 %	256 M ₩
National Pension Service of Korea 6.089 %	2,916,408	6.089 %	59 M ₩
Korea Investment Partners Co., Ltd. 4.853 %	2,324,122	4.853 %	47 M ₩
Jae-Cheon Lee 1.559 %	746,525	1.559 %	15 M ₩
Won-Gyu Yoo 1.434 %	687,000	1.434 %	14 M ₩
Ju-yeon Yoo 0.5185 %	248,300	0.5185 %	5 M ₩
Ji-min Song 0.2238 %	107,200	0.2238 %	2 M ₩
Jae-ho Jung 0.2088 %	100,000	0.2088 %	2 M ₩
Seung-Sin Lee 0.1019 %	48,781	0.1019 %	981 961 ₩
Jong-hyun Lee 0.1019 %	48,781	0.1019 %	981 961 ₩

ABL Bio, Inc.

16 Daewangpangyo-ro 712beon-gil Bundang-gu

13488, Seongnam-si

+82 31 8018 9800

http://www.ablbio.com

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
ABL BIO INC.	+5.69%	919M
VERTEX PHARMACEUTICALS INCORPORATED	-3.14%	102B
REGENERON PHARMACEUTICALS, INC.	+1.65%	96.29B
ARGENX SE	+2.13%	22.18B
BIONTECH SE	-15.80%	21.2B
GENMAB A/S	-9.21%	18.31B
WUXI APPTEC CO., LTD.	-39.98%	17.38B
BEIGENE, LTD.	-14.77%	16.36B
NEUROCRINE BIOSCIENCES, INC.	+5.06%	13.97B
SAREPTA THERAPEUTICS, INC.	+32.61%	12.17B

Bio Therapeutic Drugs